Navigation Links
LifeVantage Announces Record Fiscal Year 2011 Results and Provides Fiscal Year 2012 Guidance
Date:9/28/2011

SALT LAKE CITY, Sept. 28, 2011 /PRNewswire/ -- LifeVantage Corporation (OTCBB: LFVN), makers of Protandim®, the Nrf2 Synergizer™ patented dietary supplement, today reported financial results for the fourth quarter and full fiscal year ended June 30, 2011 and issued fiscal year 2012 revenue and operating income guidance.

(Logo:  http://photos.prnewswire.com/prnh/20090930/LIFEVANTAGELOGO)

Fiscal 2011 Fourth Quarter ResultsFor the fourth fiscal quarter ended June 30, 2011, the Company reported record net revenue of $15.0 million compared to $4.4 million for the same period in fiscal 2010, an increase of 241% from the prior year period.  On a sequential basis, net revenue increased 50% from the $10.0 million reported for the third fiscal quarter ended March 31, 2011.  

Gross profit for the fourth quarter of fiscal 2011 increased to $12.9 million compared to $3.7 million for the same period last year, delivering an improved gross margin of approximately 86%, compared to 83% for the same period last year.Operating expenses for the fourth fiscal quarter of 2011 were $11.0 million compared to $4.0 million for the same period last year, and on a sequential basis increased 45% from $7.6 million in the third fiscal quarter of 2011.  The increase on a sequential basis is due primarily to increased sales commissions which are a direct result of the Company's increased revenue.  The increase also reflects greater investment in personnel and infrastructure to position the Company for future growth.

Operating income improved to $2.0 million for the fourth fiscal quarter of 2011 compared to a loss of $290 thousand in the same period last year.  The fourth quarter of fiscal 2011 is the Company's fourth consecutive quarter of achieving operating income.  O
'/>"/>

SOURCE LifeVantage Corporation
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related medicine technology :

1. LifeVantage to Present at Rodman & Renshaw Annual Global Investment Conference
2. LifeVantage Announces Preliminary Third Quarter 2011 Revenue
3. LifeVantage Announces Settlement of Zrii Litigation
4. LifeVantage Announces Unaudited First Quarter Fiscal 2010 Financial and Operating Results
5. LifeVantage Announces Preliminary Unaudited First Quarter Revenue
6. LifeVantage Announces Fourth Quarter and Fiscal Year 2009 Financial and Operating Results
7. Visionsense Corp Announces 500 Patients Milestone With Neurosurgical 3D Camera at Emory University Hospital in Atlanta, GA
8. Traq3D Announces Next Generation Full Body Interactive Fitness Experience with 3D Image Sensor
9. Spaulding Clinical Announces Strategic Partnership with GrandCare Systems, Delivering Integrated Home Diagnostic ECG Monitoring
10. Marshall Edwards Announces $2 Million Private Placement
11. Dynatronics Announces Fourth Quarter and Year-end Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/6/2015)... 2015   Cepheid (Nasdaq: CPHD ) today ... 2015 second quarter ended June 30, 2015 on Thursday, ... The Company will host a management presentation ... 2015, to discuss the results.  To access the live ... at least 15 minutes before the scheduled start time ...
(Date:7/6/2015)... China Information Technology, Inc. (the "Company" or ... cloud-based platform, exchange, and big data solutions in ... launched its mobile app for Healthcare One Pass, ushering ... mobile devices. The Company jointly hosted the launch ceremony ... and Shenzhen News Net.   The mobile app ...
(Date:7/4/2015)... , Spanje, July 4, 2015 /PRNewswire/ ... Y-90 harsmicrosferen aan eerstelijns chemotherapie voor patiënten ... lever (mCRC) verlengt de progressievrije overleving in ... niet-resectabele, gemetastaseerde colorectale kanker (mCRC) die alleen ... verbetering gezien in progressievrije overleving (PFS) in ...
Breaking Medicine Technology:CNIT Launches the Mobile App for Healthcare One Pass 2CNIT Launches the Mobile App for Healthcare One Pass 3CNIT Launches the Mobile App for Healthcare One Pass 4Nieuwe SIRFLOX onderzoeksgegevens gepresenteerd op World Congress of Gastrointestinal Cancer 2Nieuwe SIRFLOX onderzoeksgegevens gepresenteerd op World Congress of Gastrointestinal Cancer 3Nieuwe SIRFLOX onderzoeksgegevens gepresenteerd op World Congress of Gastrointestinal Cancer 4Nieuwe SIRFLOX onderzoeksgegevens gepresenteerd op World Congress of Gastrointestinal Cancer 5
... EDISON, N.J., Dec. 7 Q-Med AB and Oceana Therapeutics, Inc. ... primary endpoints for the treatment of fecal incontinence. , Q-Med AB ... the FDA during the first quarter of 2010 based on the ... result of years of hard work as we developed a product ...
... , SAN DIEGO, Dec. 7 CareFusion (NYSE: ... six new Pyxis® medication management products at the 44th American ... Exhibition Dec. 6 -10 in Las Vegas. , CareFusion is ... Pyxis products rank number one in user satisfaction ratings by ...
Cached Medicine Technology:Q-Med AB and Oceana Therapeutics, Inc. Take Major Step Towards SOLESTA(TM) US Regulatory Filing 2Q-Med AB and Oceana Therapeutics, Inc. Take Major Step Towards SOLESTA(TM) US Regulatory Filing 3CareFusion Announces Six New Pyxis(R) Technologies at the ASHP Midyear Clinical Meeting and Exhibition 2CareFusion Announces Six New Pyxis(R) Technologies at the ASHP Midyear Clinical Meeting and Exhibition 3
(Date:7/7/2015)... , ... July 07, 2015 , ... ... Health (NIWH) have jointly announced a partnership focused on providing knowledge organizing ... case studies. The study will be conducted with NIWH trained patient health educators, ...
(Date:7/7/2015)... ... July 07, 2015 , ... ... has announced the release of Service Pack 5600 for its Call Accounting ... of enhancements to the already robust capabilities of the reporting platform, including ...
(Date:7/7/2015)... ... July 07, 2015 , ... Clarion ... labels, has been featured in the latest issue of In Compliance Magazine, a ... In Compliance delivers the latest news, standards updates, technical explanations and guidance, ...
(Date:7/7/2015)... ... July 07, 2015 , ... ... they have been selected by the Department of Vermont Health Access to provide ... Management Information System (MMIS) and Integrated Contact Center System project. , Vermont is ...
(Date:7/6/2015)... ... July 07, 2015 , ... Currently, mobile testing is ... AIDS, advances in the molecular diagnostic technologies, wide availability of immunosuppressive drugs and ... technologies and genetic engineering also open lucrative opportunities for the market players. , ...
Breaking Medicine News(10 mins):Health News:Isabel Healthcare and the National Institute of Whole Health Announce Partnership for a Pilot Study Using the Isabel Diagnostic Support Tool and Knowledge Organizer 2Health News:Isabel Healthcare and the National Institute of Whole Health Announce Partnership for a Pilot Study Using the Isabel Diagnostic Support Tool and Knowledge Organizer 3Health News:ISI Telemanagement Solutions, Inc. Releases Service Pack 5600 for Infortel® Select 2Health News:Standards Considerations for Laser Safety Labels from Clarion Safety Systems Featured in In Compliance Magazine 2Health News:Standards Considerations for Laser Safety Labels from Clarion Safety Systems Featured in In Compliance Magazine 3Health News:Standards Considerations for Laser Safety Labels from Clarion Safety Systems Featured in In Compliance Magazine 4Health News:CSG Government Solutions Selected by the Department of Vermont Health Access to Provide Quality Assurance and Independent Verification and Validation Services 2Health News:World Infectious Disease Testing Market Examined by VPGMarketResearch.com in In-Demand Report Available at MarketPublishers.com 2Health News:World Infectious Disease Testing Market Examined by VPGMarketResearch.com in In-Demand Report Available at MarketPublishers.com 3
... of Medicine have identified "secondary over-triage" as a potential area ... of over-triage occurs when patients are transferred twice, and discharged ... findings will be published in the September 10th issue of ... the number of times patients are transferred, we can evaluate ...
... the John Theurer Cancer Center at Hackensack University Medical Center ... the Food & Drug Administration,s (FDA) recent fast tracking of ... its decision largely on the results of a pivotal study ... on August 19, 2010 the same day the agency ...
... , THURSDAY, Sept. 9 (HealthDay News) -- A new study ... a child,s brain is maturing properly, potentially providing an early ... the strategy could turn an ordinary brain scan into a ... if kids are growing at an appropriate rate. "It,s ...
... 2010 News media and others interested in the ... a series of American Chemical Society (ACS) Webinars, focusing ... small business funding programs. Scheduled for Thursday, Sept. ... ACS Webinar will feature Josephine Yuen, Ph.D., NSF Program ...
... HealthDay Reporter , THURSDAY, Sept. 9 (HealthDay News) -- Two new ... smoking men who may become fathers, and in sons born to ... both men and women who hope to conceive should kick the ... biological effect of smoking on spermatozoa DNA integrity," said the lead ...
... , WEDNESDAY, Sept. 8 (HealthDay News) -- Statins, lauded ... attacks and strokes, may also reduce the risk of ... "We found that statin users who purchased their medication ... a long follow-up period," said lead researcher Gabriel Chodick, ...
Cached Medicine News:Health News:Promising treatment for metastatic melanoma 'fast tracked' by FDA 2Health News:Promising treatment for metastatic melanoma 'fast tracked' by FDA 3Health News:Brain Scans Could Spot Developmental Problems in Kids 2Health News:American Chemical Society Webinar focuses on NSF's small business funding programs 2Health News:Smoking Could Harm Sperm, Study Finds 2Health News:Smoking Could Harm Sperm, Study Finds 3Health News:Statins May Guard Against Rheumatoid Arthritis 2Health News:Statins May Guard Against Rheumatoid Arthritis 3
... Captique is a non-animal stabilized ... newest HA filler to enter the ... correction of moderate to severe facial ... folds). Captique is injected just under ...
... Radiesse brings you into the new ... can now offer your patients immediate, long-term ... and flexibility. This injectable filler offers superior ... cosmetic and reconstructive treatments. Long-lasting, Radiesse saves ...
The HEMOCHRON Model 401 is a portable, single-well whole blood coagulation monitoring instrument. The 401 provides on-screen plasma equivalent PT and APTT test results....
... clinically proven to reduce the appearance of ... formula combines Retinol, the purest form of ... It works deep within skin's surface to ... appearance. Fast absorbing, it has a fresh, ...
Medicine Products: